Related Experiment Videos
Enteric protein loss after the Fontan operation
C A Davis1, D J Driscoll, J Perrault
1Mayo Medical School, Mayo Clinic Rochester, MN 55905.
Insights
Excessive enteric protein loss and protein-losing enteropathy are uncommon in the early period after the Fontan operation. This study found a low frequency of these conditions within the first four months post-procedure.
Area of Science:
- Cardiology
- Gastroenterology
- Pediatric Surgery
Background:
- The Fontan operation is a palliative procedure for complex congenital heart disease.
- Enteric protein loss and protein-losing enteropathy are potential complications following cardiac surgery.
- Early assessment of these complications after the Fontan procedure is crucial for patient management.
Purpose of the Study:
- To determine the incidence of excessive enteric protein loss.
- To evaluate the frequency of protein-losing enteropathy.
- To assess these complications in the early post-Fontan operation period.
Main Methods:
- Twenty-six patients undergoing the Fontan procedure were studied.
- Alpha 1-antitrypsin clearance and fecal concentration were measured at two intervals within 4 months post-operation.
- Patients were evaluated between January and June 1990 at the Mayo Clinic.
Main Results:
- All patients had normal alpha 1-antitrypsin clearance in the first postoperative testing period (2-8 weeks).
- In the second testing period, all 17 evaluated patients showed normal clearances.
- One patient experienced transient protein-losing enteropathy with increased fecal alpha 1-antitrypsin concentration.
Conclusions:
- Excessive enteric protein loss is infrequent in the early phase after the Fontan operation.
- Protein-losing enteropathy is also relatively uncommon within the first 4 months post-procedure.
- These findings suggest a low risk of significant enteric protein loss early after Fontan palliation.
Objective:
The current study was undertaken to assess the frequency of excessive enteric protein loss and protein-losing enteropathy in the relatively early period after the Fontan operation.
Design:
Protein excretion was determined in 26 of 27 consecutive patients who underwent the Fontan procedure between January and June 1990 at the Mayo Clinic.
Material And Methods:
At two testing intervals during the first 4 months after the Fontan operation, alpha 1-antitrypsin clearance and fecal alpha 1-antitrypsin concentration studies were done.
Results:
All results were normal for the first postoperative test period (2 to 8 weeks). For the second study period, all 17 patients tested had normal alpha 1-antitrypsin clearances. One of the 17 patients had an appreciably increased fecal alpha 1-antitrypsin concentration and transient protein-losing enteropathy.
Conclusion:
Excessive enteric protein loss and protein-losing enteropathy are relatively uncommon during the first 4 months after the Fontan operation.